UNSPSC 51282504: Cefaloglycin or cephaloglycin

This classification denotes a cephalosporin antibiotic with the molecular structure C18H19N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, HD2D469W6U chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6r-(6.alpha.,7.beta.(r*))) but generally known as cefaloglycin, which bears US NIH Compound Identifier 19150. European Medicines Agency schedules Cefaloglycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06166MIG.

The term CEFALOGLYCIN is an International Non-Proprietary Name or INN. Cefaloglycin or cephaloglycin bears US NLM identifiers UMLS ID C0007721 and NCI Concept Code C65307. SMILES: S1C2N(C(=O)C2NC(=O)C(N)C2CCCCC2)C(=C(C1)COC(=O)C)C(=O)O.

UNSPSC 51282504 Cefaloglycin or cephaloglycin is a Commodity code that reflects minimal recent state and local procurement activity aligned with its nominal scope. The two opportunities tagged under this code in the recent posting stream do not involve cefaloglycin procurement: the Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, and Seminole County, Florida posted an IFB for Naloxone and Safe Drug Deactivation Systems. Neither represents demand for the antibiotic named in the code.

State and local procurement activity under this code appears to be dormant or misfiled at present. No open solicitations for cefaloglycin itself are visible in the recent-opportunities record. The two awards tagged to the code cover entirely different pharmaceutical products and do not signal sustainable demand for cefaloglycin from state departments, counties, or other local bodies. Business development professionals evaluating this code should treat it as inactive until evidence of actual cefaloglycin procurement emerges in state and local notices.